Aflatoxin Literature: Other Cancer

 

 

Livingstone MC, Johnson NM, Roebuck BD, Kensler TW, Groopman JD. Profound changes in miRNA expression during cancer initiation by aflatoxinB1 and their abrogation by the chemopreventive triterpenoid CDDO-Im. Mol Carcinog. 2017 Feb 20. PMID: 28218475

Koshiol J, Gao YT, Dean M, Egner P, Nepal C, Jones K, Wang B, Rashid A, Luo W, Van Dyke AL, Ferreccio C, Malasky M, Shen MC, Zhu B, Andersen JB, Hildesheim A, Hsing AW, Groopman J. Association of Aflatoxin and Gallbladder Cancer. Gastroenterology. 2017 Apr 17. PMID: 28428144

Nohmi T, Masumura K, Toyoda-Hokaiwado N. Transgenic rat models for mutagenesis and carcinogenesis. Genes Environ. 2017 Feb 1;39:11. PMID: 28174618

Ostry V, Malir F, Toman J, Grosse Y. Mycotoxins as human carcinogens-the IARC Monographs classification. Mycotoxin Res. 2017 Feb;33(1):65-73. PMID: 27888487

Ikoma T, Kapoor VK, Behari A, Mishra K, Tsuchiya Y, Asai T, Endoh K, Okano K, Nakamura K. Lack of an Apparent Association between Mycotoxin Concentrations in Red Chili Peppers and Incidence of Gallbladder Cancer in India : an Ecological Study. Asian Pac J Cancer Prev. 2016;17(7):3499-503. PMID: 27509999

Foerster C, Koshiol J, Guerrero AR, Kogan MJ, Ferreccio C. The case for aflatoxins in the causal chain of gallbladder cancer. Med Hypotheses. 2016 Jan;86:47-52. PMID: 26804596

Kim J, Park SH, Do KH, Kim D, Moon Y. Interference with mutagenic aflatoxin B1-induced checkpoints through antagonistic action of ochratoxin A in intestinal cancer cells: a molecular explanation on potential risk of crosstalk between carcinogens. Oncotarget. 2016 Jun 28;7(26):39627-39639. PMID: 27119350

Chappell G, Pogribny IP, Guyton KZ, Rusyn I. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review. Mutat Res Rev Mutat Res. 2016 Apr-Jun;768:27-45. PMID: 27234561

Abassi H, Ayed-Boussema I, Shirley S, Abid S, Bacha H, Micheau O. The mycotoxin zearalenone enhances cell proliferation, colony formation and promotes cell migration in the human colon carcinoma cell line HCT116. Toxicol Lett. 2016 Jul 8;254:1-7. PMID: 27084041

De Ruyck K, De Boevre M, Huybrechts I, De Saeger S. Dietary mycotoxins, co-exposure, and carcinogenesis in humans: Short review. Mutat Res Rev Mutat Res. 2015 Oct-Dec;766:32-41. PMID: 26596546

Cui A, Hua H, Shao T, Song P, Kong Q, Luo T, Jiang Y. Aflatoxin B1 induces Src phosphorylation and stimulates lung cancer cell migration. Tumour Biol. 2015 Aug;36(8):6507-13. PMID: 25820822

Effect of 8-oxoguanine glycosylase deficiency on aflatoxin B1 tumourigenicity in mice. Mulder JE, Turner PV, Massey TE. Mutagenesis. 2015 May;30(3):401-9. PMID: 25583175

Liu C, Shen H, Yi L, Shao P, Soulika AM, Meng X, Xing L, Yan X, Zhang X. Oral administration of aflatoxin G₁ induces chronic alveolar inflammation associated with lung tumorigenesis. Toxicol Lett. 2015 Feb 3;232(3):547-56. PMID: 25445582

Frehse MS, Martins MI, Ono EY, Bracarense AP, Bissoqui LY, Teixeira EM, Santos NJ, Freire RL. Aflatoxins ingestion and canine mammary tumors: There is an association. Food Chem Toxicol. 2015 Oct;84:74-8. PMID: 26271706

Saad-Hussein A, Taha MM, Beshir S, Shahy EM, Shaheen W, Elhamshary M. Carcinogenic effects of aflatoxin B1 among wheat handlers. Int J Occup Environ Health. 2014 Jul-Sep;20(3):215-9. PMID: 25000109

Eom Sang-Yong Y., Yim Dong-Hyuk H., Zhang Yanwei, et al. Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean. Cancer causes & control : CCC. 2013;24:1963–1972.

Yen Chia-Hung H., Lin Yu-Ting T., Chen Heng-Li L., Chen Shih-Yin Y., Chen Yi-Ming Arthur M.. The multi-functional roles of GNMT in toxicology and cancer. Toxicology and applied pharmacology. 2013;266:67–75.

Ghasemi-Kebria Fatemeh, Joshaghani Hamidreza, Taheri Negar Sadat S., et al. Aflatoxin contamination of wheat flour and the risk of esophageal cancer in a high risk area in Iran. Cancer epidemiology. 2013;37:290–293.

Carvajal Magda, Berumen Jaime, Guardado-Estrada Mariano. The presence of aflatoxin B₁-FAPY adduct and human papilloma virus in cervical smears from cancer patients in Mexico. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment. 2012;29:258–268.

Asai Takao, Tsuchiya Yasuo, Okano Kiyoshi, et al. Aflatoxin contamination of red chili pepper from Bolivia and Peru, countries with high gallbladder cancer incidence rates. Asian Pacific journal of cancer prevention : APJCP. 2012;13:5167–5170.

Misumi Junichi. [The mechanisms of gastric cancer development produced by the combination of Helicobacter pylori with Sterigmatocystin, a mycotoxin]. Nihon rinsho. Japanese journal of clinical medicine. 2004;62:1377–1386.

Olivier Magali, Hussain S. Perwez, Fromentel Claude, Hainaut Pierre, Harris Curtis C.. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC scientific publications. 2004:247–270.

Sudakin Daniel L.. Dietary aflatoxin exposure and chemoprevention of cancer: a clinical review. Journal of toxicology. Clinical toxicology. 2003;41:195–204.

Lane K. S.. Aflatoxin, Tobacco, Ammonia and the p53 Tumor-Suppressor Gene: Cancer’s Missing Link? MedGenMed : Medscape general medicine. 1999.

Pierzynowska J., Grzesiuk E.. [Mutagenicity an carcinogenicity of aflatoxin AFB1]. Postepy biochemii. 1999;45:313–319.

Riley J., Mandel H. G., Sinha S., Judah D. J., Neal G. E.. In vitro activation of the human Harvey-ras proto-oncogene by aflatoxin B1. Carcinogenesis. 1997;18:905–910.

Massey T. E.. The 1995 Pharmacological Society of Canada Merck Frosst Award. Cellular and molecular targets in pulmonary chemical carcinogenesis: studies with aflatoxin B1. Canadian journal of physiology and pharmacology. 1996;74:621–628.

Kolars J. C., Benedict P., Schmiedlin-Ren P., Watkins P. B.. Aflatoxin B1-adduct formation in rat and human small bowel enterocytes. Gastroenterology. 1994;106:433–439.

Hsieh L. L., Hsieh T. T.. Detection of aflatoxin B1-DNA adducts in human placenta and cord blood. Cancer research. 1993;53:1278–1280.

Wogan G. N.. Aflatoxin carcinogenesis: interspecies potency differences and relevance for human risk assessment. Progress in clinical and biological research. 1992;374:123–137.

Zawirska B.. Aflatoxin carcinogenesis in Wistar rats enhanced by thyroideum POLFA. Materia medica Polona. Polish journal of medicine and pharmacy. 1991;23:191–194.

Bosch F. X., Peers F.. Aflatoxins: data on human carcinogenic risk. IARC scientific publications. 1991:48–53.

Ball R. W., Wilson D. W., Coulombe R. A.. Comparative formation and removal of aflatoxin B1-DNA adducts in cultured mammalian tracheal epithelium. Cancer research. 1990;50:4918–4922.

Groopman J. D., Cain L. G., Kensler T. W.. Aflatoxin exposure in human populations: measurements and relationship to cancer. Critical reviews in toxicology. 1988;19:113–145.

Hsieh L. L., Hsu S. W., Chen D. S., Santella R. M.. Immunological detection of aflatoxin B1-DNA adducts formed in vivo. Cancer research. 1988;48:6328–6331.

Albertini S., Friederich U., Holderegger C., Würgler F. E.. The in vitro porcine brain tubulin assembly assay: effects of a genotoxic carcinogen (aflatoxin B1), eight tumor promoters and nine miscellaneous substances. Mutation research. 1988;201:283–292.

Groopman J. D.. Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment? IARC scientific publications. 1988:55–62.

Wood M. L., Smith J. R., Garner R. C.. Structural characterization of the major adducts obtained after reaction of an ultimate carcinogen aflatoxin B1-dichloride with calf thymus DNA in vitro. Cancer research. 1988;48:5391–5396.

Groopman J. D., Donahue K. F.. Aflatoxin, a human carcinogen: determination in foods and biological samples by monoclonal antibody affinity chromatography. Journal – Association of Official Analytical Chemists. 1988;71:861–867.

Olsen J. H., Dragsted L., Autrup H.. Cancer risk and occupational exposure to aflatoxins in Denmark. British journal of cancer. 1988;58:392–396.

Gan L. S., Skipper P. L., Peng X. C., et al. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis. 1988;9:1323–1325.

Sabbioni G., Skipper P. L., Büchi G., Tannenbaum S. R.. Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats. Carcinogenesis. 1987;8:819–824.

Cullen J. M., Ruebner B. H., Hsieh L. S., Hyde D. M., Hsieh D. P.. Carcinogenicity of dietary aflatoxin M1 in male Fischer rats compared to aflatoxin B1. Cancer research. 1987;47:1913–1917.

Shamsuddin A. M., Harris C. C., Hinzman M. J.. Localization of aflatoxin B1–nucleic acid adducts in mitochondria and nuclei. Carcinogenesis. 1987;8:109–114.

Hsieh D. P., Cullen J. M., Hsieh L. S., Shao Y., Ruebner B. H.. Cancer risks posed by aflatoxin M1. Princess Takamatsu symposia. 1985;16:57–65.

Duraković S.. [Mycotoxins as carcinogenic agents]. Lijec̆nic̆ki vjesnik. 1985;107:530–537.

Bodine A. B., Luer C. A., Gangjee S.. A comparative study of monooxygenase activity in elasmobranchs and mammals: activation of the model pro-carcinogen aflatoxin B1 by liver preparations of calf, nurse shark and clearnose skate. Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology. 1985;82:255–257.

Bhattacharya R. K., Firozi P. F., Aboobaker V. S.. Factors modulating the formation of DNA adduct by aflatoxin B1 in vitro. Carcinogenesis. 1984;5:1359–1362.

Masri M. S.. Defenses against aflatoxin carcinogenesis in humans. Advances in experimental medicine and biology. 1984;177:115–146.

Akintonwa D. A.. Some aspects of the human carcinogenicity of aflatoxin B1 and 3, 4 benz [a] pyrene. International journal of epidemiology. 1982;11:293–294.

Zamfir G., Răileanu L.. [Mycotoxins as toxic and carcinogenic pollutants]. Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i. 1982;86:393–396.

Moore M. R., Pitot H. C., Miller E. C., Miller J. A.. Cholangiocellular carcinomas induced in Syrian golden hamsters administered aflatoxin B1 in large doses. Journal of the National Cancer Institute. 1982;68:271–278.

Bababunmi E. A., Emerole G. O., Uwaifo A. O., Thabrew M. I.. The role of aflatoxins and other aromatic hydrocarbons in human carcinogenesis. IARC scientific publications. 1982:395–403.

Stoner G. D., Daniel F. B., Schenck K. M., Schut H. A., Sandwisch D. W., Gohara A. F.. DNA binding and adduct formation of aflatoxin B1 in cultured human and animal tracheobronchial and bladder tissues. Carcinogenesis. 1982;3:1345–1348.

Zawirska B.. The particular traits of carcinogenesis induced in Wistar rats by aflatoxin B1. IV. Porphyrins and the activity of gamma-glutamyltranspeptidase in Wistar rats bearing transplantable hepatoma. Neoplasma. 1982;29:693–707.

McCoy B. J., Llewellyn G. C.. Response of culture human skin fibroblasts to aflatoxin B1. Bulletin of environmental contamination and toxicology. 1980;25:7–14.

Selkirk J. K.. Chemical carcinogenesis: a brief overview of the mechanism of action of polycyclic hydrocarbons, aromatic amines, nitrosamines, and aflatoxins. Carcinogenesis; a comprehensive survey. 1980;5:1–31.

Hendricks J. D., Sinnhuber R. O., Nixon J. E., Wales J. H., Masri M. S., Hsieh D. P.. Carcinogenic response of rainbow trout (Salmo gairdneri) to aflatoxin Q1 and synergistic effect of cyclopropenoid fatty acids. Journal of the National Cancer Institute. 1980;64:523–528.

Zawirska B.. [Selected characteristics of carcinogenesis in Wistar rats induced by aflatoxin B1. I. Morphological changes and glutamyl transpeptidase activity]. Patologia polska. 1979;30:439–456.

Carlborg F. W.. Cancer, mathematical models and aflatoxin. Food and cosmetics toxicology. 1979;17:159–166.

Butler W. H., Neal G. E.. Mode of action and human health aspects of aflatoxin carcinogenesis. Annales de la nutrition et de l’alimentation. 1977;31:949–956.

Sahaphong S., Naka L.. Volume change induced in ascites sarcoma cells by aflatoxin B1. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 1977;60:208–212.

Judah D. J., Legg R. F., Neal G. E.. Development of resistance to cytotoxicity during aflatoxin carcinogenesis. Nature. 1977;265:343–345.

Deger G. E.. Letter: Aflatoxin–human colon carcinogenesis? Annals of internal medicine. 1976;85:204–205.

Miller J. A., Miller E. C.. Carcinogens occurring naturally in foods. Federation proceedings. 1976;35:1316–1321.

Dvorácková I.. Aflatoxin inhalation and alveolar cell carcinoma. British medical journal. 1976;1.

Aflatoxins. IARC monographs on the evaluation of carcinogenic risk of chemicals to man. 1976;10:51–72.

Swenson D. H., Miller J. A., Miller E. C.. The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1. Cancer research. 1975;35:3811–3823.

Canton J. H., Kroes R., Logten M. J., Schothorst M., Stavenuiter J. F., Verhülsdonk C. A.. The carcinogenicity of aflatoxin M1 in rainbow trout. Food and cosmetics toxicology. 1975;13:441–443.

Wray B. B., O’Steen K. G.. Mycotoxin-producing fungi from house associated with leukemia. Archives of environmental health. 1975;30:571–573.

Wogan G. N., Paglialunga S., Newberne P. M.. Carcinogenic effects of low dietary levels of aflatoxin B1 in rats. Food and cosmetics toxicology. 1974;12:681–685.

Wogan G. N., Paglialunga S.. Carcinogenicity of synthetic aflatoxin M1 in rats. Food and cosmetics toxicology. 1974;12:381–384.

Shalkop W. T., Armbrecht B. H.. Carcinogenic response of brood sows fed aflatoxin for 28 to 30 months. American journal of veterinary research. 1974;35:623–627.

Lindenfelser L. A., Lillehoj E. B., Burmeister H. R.. Aflatoxin and trichothecene toxins: skin tumor induction and synergistic acute toxicity in white mice. Journal of the National Cancer Institute. 1974;52:113–116.

Kremen J., Lexová J+LEXOVA J., Sula J.. On influence of aflatoxin B1 on the physical properties of the avian myeloblastosis virus BAI strain A (AMV) and on the biosynthesis of viral nucleic acids. Neoplasma. 1974;21:275–283.

Aleksandrowicz J., Smyk B.. The association of neoplastic diseases and mycotoxins in the environment. Texas reports on biology and medicine. 1973;31:715–726.

Beloshapko A. A.. [Toxicity and carcinogenicity of aflatoxin]. Patologicheskaia fiziologiia i èksperimental’naia terapiia. 1972;16:83–88.

Enomoto M., Saito M.. Carcinogens produced by fungi. Annual review of microbiology. 1972;26:279–312.

Aleksandrowicz J., Smyk B.. [Mycotoxins and their role in the etiology of neoplasms in man and animals]. Polskie Archiwum Medycyny Wewnętrznej. 1971;47:331–338.

Wogan G. N., Edwards G. S., Newberne P. M.. Structure-activity relationships in toxicity and carcinogenicity of aflatoxins and analogs. Cancer research. 1971;31:1936–1942.

Teichmann R.. [Pathogenic mould. Aspergillus fumigatus as cause of malignant tumor]. Zeitschrift für ärztliche Fortbildung. 1970;64:143–146.

Toyoshima K., Hiasa Y., Ito N., Tsubura Y.. In vitro malignant transformation of cells derived from rat liver by means of aflatoxin B1. Gann = Gan. 1970;61:557–561.

Galikeev Kh h. L.. [On the carcinogenic activity of aflatoxins]. Voprosy onkologii. 1969;15:106–108.

Butler W. H., Barnes J. M.. Carcinogenic action of groundnut meal containing aflatoxin in rats. Food and cosmetics toxicology. 1968;6:135–141.

Wieder R., Wogan G. N., Shimkin M. B.. Pulmonary tumors in strain A mice given injections of aflatoxin B1. Journal of the National Cancer Institute. 1968;40:1195–1197.

Newberne P. M., Wogan G. N.. Sequential morphologic changes in aflatoxin B carcinogenesis in the rat. Cancer research. 1968;28:770–781.

Lijinsky W.. Aflatoxins and nitrosamines: cellular interactions and carcinogenesis. The New Zealand medical journal. 1968;67.

Newberne P. M., Hunt C. E., Wogan G. N.. Neoplasms in the rat associated with administration of urethan and aflatoxin. Experimental and molecular pathology. 1967;6:285–299.

Wogan G. N., Newberne P. M.. Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat. Cancer research. 1967;27:2370–2376.

Childs V. A., Legator M. S.. Induction of thymidine kinase by aflatoxin. Life sciences. 1966;5:1053–1056.

Butler W. H., Barnes J. M.. Carcinoma of the glandular stomach in rats given diets containing aflatoxin. Nature. 1966;209.

Richir C., Martineaud M.. [Cancers and fungal contamination of foods]. Concours médical. 1965;87:4067–4076.

Barnes J., Butler W.H. Carcinogenic activity of aflatoxin to rats. Nature. 1964;202.

Dickens, F., Jones H.E. The carcinogenic action of aflatoxin after its subcutaneous injection in the rat. British journal of cancer. 1963;17:691–698.